{"id":255931,"date":"2020-05-24T07:45:03","date_gmt":"2020-05-24T11:45:03","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=255931"},"modified":"2020-05-24T07:45:03","modified_gmt":"2020-05-24T11:45:03","slug":"cease-and-desist-order-issued-vs-unregistered-fabunan-drug","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/05\/24\/cease-and-desist-order-issued-vs-unregistered-fabunan-drug\/","title":{"rendered":"Cease and desist order issued vs. unregistered Fabunan drug"},"content":{"rendered":"<figure id=\"attachment_250787\" aria-describedby=\"caption-attachment-250787\" style=\"width: 415px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/04\/8648271410814296888725793309244053568094208n.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-250787 size-full\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/04\/8648271410814296888725793309244053568094208n.jpg\" alt=\"\" width=\"415\" height=\"260\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/04\/8648271410814296888725793309244053568094208n.jpg 415w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/04\/8648271410814296888725793309244053568094208n-300x188.jpg 300w\" sizes=\"auto, (max-width: 415px) 100vw, 415px\" \/><\/a><figcaption id=\"caption-attachment-250787\" class=\"wp-caption-text\">FILE: Health Assistant Secretary Maria Rosario Vergeire in a press briefing Monday (Feb. 17, 2020). (PNA photo by Ma. Teresa Montemayor)<\/figcaption><\/figure>\n<p><strong>MANILA<\/strong>\u00a0\u2013 The Food and Drug Administration (FDA) has issued a cease and desist order against the unregistered Fabunan antiviral injections which are considered as cure for the coronavirus disease 2019 (Covid-19), an official of the Department of Health (DOH) said Sunday.<\/p>\n<p>&#8220;They still have not applied for CPR (certificate of product registration). They were already issued a cease and desist order by FDA, case buildup is being done already,&#8221; DOH Undersecretary Maria Rosario Vergeire said in a text message to reporters.<\/p>\n<p>Vergeire added that the DOH is already studying cases related to the drug as social media posts showing its use in a vaccine drive in Zambales circulated anew.<\/p>\n<p>&#8220;We are studying the case already. FDA has jurisdiction when it comes to the unregistered drug or vaccine, and PRC (Professional Regulation Commission) for the practice of medicine,&#8221; she said.<\/p>\n<p>On April 22, the palace urged the FDA to study the effectiveness of the Fabunan antiviral injection in curing patients with Covid-19.<\/p>\n<p>Earlier, a video about the drug circulated on social media.<\/p>\n<p>The video conveyed that Fabunan is a patented antiviral drug against dengue developed by Washington-based Filipino doctor Ruben Fabunan and that it is an \u201capproved\u201d drug and has been \u201cproven to be used to treat Covid-19\u201d.<\/p>\n<p>The FDA warned the public that no drug and vaccine has been licensed \u201cspecifically for use in Covid-19 treatment&#8221;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANILA\u00a0\u2013 The Food and Drug Administration (FDA) has issued a cease and desist order against the unregistered Fabunan antiviral injections &hellip;<\/p>\n","protected":false},"author":44,"featured_media":250787,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,95],"tags":[],"class_list":["post-255931","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-ph","mauthors-ma-teresa-montemayor","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/255931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=255931"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/255931\/revisions"}],"predecessor-version":[{"id":255932,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/255931\/revisions\/255932"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/250787"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=255931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=255931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=255931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}